Keyphrases
Rheumatoid Arthritis
100%
Early Rheumatoid Arthritis
60%
Inception Cohort
45%
Disease Activity
29%
Disease Activity Score 28 (DAS28)
26%
Health Assessment Questionnaire
23%
Comorbidity
20%
Early RA
19%
Disease-modifying Antirheumatic Drugs (DMARDs)
17%
Orthopedic Surgery
16%
Methotrexate
16%
Inflammation
13%
Single Technology Appraisal
12%
Evidence Review
12%
National Institutes of Health
10%
Arthritis
10%
Rheumatoid Arthritis Treatment
10%
Radiographic Progression
10%
Large Joints
10%
Orthopedic Interventions
10%
Previously Treated
9%
Interstitial Lung Disease
9%
Rheumatology
9%
Secular Change
9%
Cost-effectiveness
8%
Inflammatory Polyarthritis
8%
Predictive Factors
8%
Tumour Necrosis Factor Inhibitor (TNFi)
8%
Rheumatologic Diseases
8%
Rheumatoid Factor
8%
Functional Limitations
8%
Remission
7%
Systematic Literature Review
7%
Drug Treatment
7%
Clinical Efficacy
7%
Conventional Disease-modifying Antirheumatic Drug
7%
Disease Activity Score
7%
Certolizumab Pegol
6%
Short Form 36 (SF-36)
6%
Treat-to-target
6%
Disability
6%
European League against Rheumatism (EULAR)
6%
Functional Disability
6%
Etanercept
6%
HLA-DRB1
6%
Psychological Distress
6%
Rheumatoid Arthritis-associated Interstitial Lung Disease
6%
Norfolk
6%
Quality-adjusted Life Years
6%
Cumulative Incidence
5%
Medicine and Dentistry
Inflammatory Arthritis
92%
Rheumatoid Arthritis
92%
Disease Activity
24%
DAS28
21%
Comorbidity
17%
Orthopedic Surgery
15%
Disease
14%
Interstitial Lung Disease
12%
Orthopedics
12%
Prevalence
10%
Rheumatoid Factor
10%
Rheumatology
9%
Systematic Review
9%
Health Assessment Questionnaire
8%
Cumulative Incidence
7%
Functional Limitation
6%
Cohort Study
6%
Arthritis
6%
Disease-Modifying Antirheumatic Drug
5%
Drug Therapy
5%
Methotrexate
5%
Cohort Analysis
5%
Patient-Reported Outcome
5%
Short Form 36
5%
Disease Activity Score
5%